Topic
prescription drugs
30 stories related to this topic, newest first.
axios.comscience5 days ago
TrumpRx Lists 92 Brand-Name Drugs from 15 Companies as of Mid-July, Up from 43 at February Launch
The government website named for President Trump offers discounts on fewer than 12 percent of the more than 800 brand-name drugs marketed by participating firms. Some major revenue-generating medicines remain unavailable while generics frequently cost less elsewhere.
science15 days ago
Medicare Drug Plans Drop Tens of Thousands Over Unpaid Premiums as Low as $8
Thousands of Medicare beneficiaries lost prescription coverage after small premium increases went unnoticed. Affected individuals cannot re-enroll until 2027 and face higher out-of-pocket costs.
world18 days ago
MassHealth Ends Medicaid Coverage of GLP-1 Drugs for Weight Loss
MassHealth will stop paying for GLP-1 medications prescribed solely for weight loss starting Friday. The change affects roughly 22,000 adults and 2,500 children enrolled in the state Medicaid program.
world19 days ago
Medicare to Cover Weight-Loss Drugs at $50 Monthly Starting July 1
Beginning July 1, Medicare will extend coverage for weight-loss medications to millions of seniors at a capped out-of-pocket cost of $50 per month. The change marks the first time such drugs receive broad federal insurance support for this population.
globalnews.capolitics20 days ago
Medicare Begins Temporary Coverage of GLP-1 Drugs for Obesity
A short-term pilot program allowing Medicare to cover GLP-1 medications for obesity treatment begins July 2 and runs through 2027. Beneficiaries will pay $50 monthly while manufacturers set a $245 price per drug. The program covers obesity treatment only and requires prior author…
cnbc.comfinance21 days ago
Medicare launches pilot offering GLP-1 obesity drugs for $50 monthly
A new Medicare pilot program will provide GLP-1 weight-loss medications to beneficiaries for $50 a month starting July 1. The initiative addresses prior cost barriers that kept these drugs out of reach for many seniors.
cnbc.comworld21 days ago
Medicare to Cover Select Weight-Loss Drugs for Two Years Starting July 2026 Under New Pilot
Some Medicare patients will access GLP-1 medications for weight loss through a new pilot program starting July 1 with a $50 monthly copay. The Medicare GLP-1 Bridge covers specific drugs from Eli Lilly and Novo Nordisk through December 2027. CBS News reported the details of eligi…
news.gallup.comscience26 days ago
U.S. Health-Care Spending Reached $5.7 Trillion in 2025
Government figures show a 7.3% rise from 2024, with per-person costs near $16,500 and prescription drug outlays up more than 11%. The FDA also cleared two new first-line treatments for advanced triple-negative breast cancer within a month.
usatoday.compolitics26 days ago
Senate bill would cap insulin costs at $35 for privately insured patients
Bipartisan legislation in the Senate would limit out-of-pocket insulin costs to $35 per month for people with commercial insurance. The measure would also create a pilot program in ten states for uninsured patients.
New York Postpolitics27 days ago
Medicare Expands Access to Weight-Loss Drugs for Seniors at $50 Copay Starting July 1
Medicare's 68 million enrollees will pay $50 for GLP-1 weight-loss drugs beginning July 1. President Trump announced the change at a Pennsylvania truck plant and linked it to his drug-pricing policy.
The Hillscience30 days ago
Medicare to Offer $50 Monthly GLP-1 Access for Weight Management Starting July
A temporary demonstration program will let some Medicare Part D enrollees obtain GLP-1 medications for a flat $50 monthly copay from July 1, 2026, through December 31, 2027. The program operates outside standard Medicare coverage rules because federal law bars payment for weight-…
earther.gizmodo.comworld30 days ago
Ivermectin prescriptions among cancer patients more than doubled in early 2025
Prescriptions for the antiparasitic drug rose sharply after a podcast episode discussed its use. Medical experts state the drug has not been proven effective against cancer in clinical trials.
AB
naturalnews.comscience31 days ago
Ivermectin prescriptions for cancer patients doubled from January to July 2025
A JAMA Network report found ivermectin prescriptions for cancer patients rose sharply after a January 2025 podcast appearance. Researchers linked the increase to celebrity comments on the Joe Rogan Experience. The study noted higher rates among white southern males.
New York Postworld35 days ago
Medicare to Offer GLP-1 Weight-Loss Drugs for $50 Monthly Starting July 1
Up to 14 million Medicare recipients who are overweight will be eligible for three GLP-1 medications at a $50 copay under a new pilot program. The Medicare GLP-1 Bridge runs from July 2026 through December 2027 and is separate from standard Part D coverage.
usatoday.comworld43 days ago
Danish Drugmaker's Pill Hits 3 Million U.S. Prescriptions in 22 Weeks
The medication accumulated one million prescriptions within 12 weeks of U.S. availability and added two million more in the next 10 weeks.
The Hillpolitics44 days agoUpdated
Trump Administration Adds 160 Drugs to TrumpRx Platform, Now Claiming Over 800 Total Available
President Trump announced the expansion on Friday. The platform now covers four out of five prescriptions filled by Americans and has saved patients more than $400 million.
fastcompany.combusiness49 days ago
Medicare to Offer Weight-Loss Drugs for $50 Monthly Starting in July
Medicare will begin covering Wegovy and Zepbound for weight loss at $50 per month for older adults in July. The agency has not disclosed the projected cost to taxpayers.
usatoday.comscience63 days ago
Supreme Court Declines to Hear Pharma Challenges to Medicare Drug Price Program
The U.S. Supreme Court declined to review lawsuits filed by six pharmaceutical companies against the Medicare drug price negotiation program. The White House separately announced an expansion of its TrumpRx discount platform through partnerships with three prescription savings se…
rediff.comscience63 days ago
Trump Administration Adds Over 600 Generic Drugs to TrumpRx Site
The White House expanded its direct-to-consumer drug platform on Monday by adding more than 600 generic medications. The move aims to increase options for cash-paying patients seeking lower prescription prices.
FI
realitytea.compolitics63 days ago
President Trump to Announce Expanded Discounted Prescription Drug Program
President Trump plans to announce an expansion of discounted prescription drug offerings. The program uses Most-Favored-Nation pricing to lower costs for Americans.
DE
ksl.comai67 days ago
Startup Reaches $1 Billion Valuation Processing Prescription Drug Paperwork With AI
The company developed software that automates administrative tasks for prescriptions including insurance routing, prior authorizations and pharmacy selection. It reported reaching a $1 billion valuation with $160 million in total funding and annualized revenue now above $50 milli…
FO
New York Postworld68 days ago
Prescriptions for Ivermectin and Fenbendazole Rose Sharply Among Cancer Patients After Podcast Discussion
A study found prescriptions for ivermectin and fenbendazole among cancer patients increased more than 2.5 times in the months after actor-director Mel Gibson discussed the drugs on a January 2025 podcast episode. The combination saw the largest increases among young men, white pa…
gizmodo.comscience69 days ago
Cancer Patients Increased Use of Ivermectin After Mel Gibson Podcast Appearance
Prescriptions for ivermectin and fenbendazole rose sharply in the months after Mel Gibson told Joe Rogan that the drugs had cured Stage 4 cancer in three of his friends. A study published in JAMA Network Open found the rate of prescriptions among cancer patients more than doubled…
Substrate placeholder — needs reviewai70 days ago
Forus Reaches $1 Billion Valuation With AI Prescription Processing Software
Forus has developed AI software that automates the administrative processing of prescriptions from the moment a physician writes them. The company reported reaching a $1 billion valuation after raising $160 million from investors including Thrive Capital, General Catalyst and Acc…
The Sydney Morning Heraldworld73 days ago
Rebekah Beddoe attributes years of severe side effects and bipolar diagnosis to sertraline and subsequent psychiatric medications
Beddoe developed insomnia, akathisia and suicidal thoughts shortly after starting sertraline for post-natal exhaustion, leading to multiple additional prescriptions, a bipolar diagnosis and repeated psychiatric admissions. She later tapered off all drugs and regained her mental h…
realclearmarkets.comscience75 days ago
Rising Health Care Costs Top Priority for MAHA Supporters in KFF Poll
A KFF poll released May 6 found that 4 in 10 adults who support the MAHA movement identified lowering health care costs, including prescription drugs, as the top health priority for the federal government. This concern outranked restricting chemical additives in food and reevalua…
medium.comworld86 days ago
Johnson & Johnson Adds Four Drugs to TrumpRx Discount Site Following Voluntary Agreement
Johnson & Johnson will begin marketing four medications on the Trump administration's TrumpRx website on Friday. The move follows a voluntary agreement announced in January that provides Medicaid access to affordable prescriptions in exchange for tariff exemptions. The addition m…
Substrate placeholder — needs reviewpolitics89 days ago
Mark Cuban Partners with TrumpRx Initiative to Lower Prescription Drug Costs
Billionaire investor Mark Cuban revealed a partnership with the Trump administration and TrumpRx to lower prescription drug costs. The initiative integrates Cost Plus Drugs' medications into TrumpRx. Cuban emphasized affordability across political lines in a Fox News appearance.
Substrate placeholder — needs reviewbusiness98 days ago
Maryland Board Establishes $204 Monthly Cap on Jardiance for Public Purchases by 2027
The Maryland Prescription Drug Affordability Board has established an upper payment limit for Jardiance, a type 2 diabetes medicine, capping its price at $204 for a 30-day supply by January 2027. The board will oversee a process to lower costs for state and local governments. The…
ST
Substrate placeholder — needs reviewfinance105 days ago
FDA Declines to Issue Guidance on Alternative Funding Programs Importing Foreign Drugs
The U.S. Food and Drug Administration has declined a request to provide specific guidance on alternative funding programs that import prescription drugs from overseas. These programs connect patients with affordable medications for critical diseases, though regulators state the i…